Welcome to our dedicated page for Wearable Devices Ltd. SEC filings (Ticker: WLDS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wearable Devices Ltd. filings document its foreign private issuer reporting for AI-powered touchless sensing wearables, Mudra neural input products and software platforms for XR, mobile and AI applications. Form 6-K reports furnish product announcements, patent notices, financial results and updates on ai6 Labs, Mudra Experience Studio, Mudra Link and Mudra Band.
The filings also cover capital-structure and governance matters, including ordinary shares and tradable warrants, reverse share split disclosure, shareholder meeting results, compensation policy amendments, equity incentive plan share reserves, and incorporation by reference into Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. (symbol WLDS) is registering for resale up to 2,000,000 Ordinary Shares held by a selling shareholder, all issued or issuable from a July 2026 private placement. This includes 240,000 existing shares, 760,000 shares from pre-funded warrants, and 1,000,000 shares from ordinary warrants.
The company will not receive proceeds from these resale transactions but may receive up to $3.16 million in cash if all pre-funded and ordinary warrants are exercised. Ordinary warrants have a $3.16 exercise price and five-year term; pre-funded warrants have a $0.0001 exercise price and are exercisable until fully used. Ordinary Shares outstanding were 2,459,741 as of August 27, 2026; if all pre-funded and ordinary warrants held by this investor are exercised, shares outstanding tied to this financing would rise to 4,219,741, and full exercise of all its warrants and pre-funded warrants outstanding as of that date would increase total Ordinary Shares from 2,459,741 to 5,914,032.
Wearable Devices develops Mudra neural input wristbands and related AI/physical-AI technologies. Revenue was $647 thousand in 2025 and $522 thousand in 2024, with net and comprehensive losses of $8.1 million and $7.9 million, respectively; for the six months ended June 30, 2026 revenue was $350 thousand and net and comprehensive loss was $5.5 million.
Wearable Devices Ltd. (WLDS) filed a post-effective amendment to its Form F-1 to update information and maintain registration for the issuance of up to 11,441 Ordinary Shares upon exercise of existing IPO Warrants and Underwriter’s Warrants issued in its 2022 IPO. No additional securities are being registered and all registration fees were previously paid.
The IPO Warrants cover 11,181 shares at an adjusted exercise price of $1,440 per share and expire on September 15, 2027; the Underwriter’s Warrants cover 260 shares at $3,823.20 per share, expiring on September 12, 2027. If fully exercised, the company would receive up to $16.1 million from IPO Warrants and $994 thousand from Underwriter’s Warrants.
WLDS develops Mudra neural-input wristbands and related AI/neurotech products and remains in a loss-making growth phase, with 2025 revenue $647 thousand and net loss $8.1 million, and first-half 2026 revenue $350 thousand and net loss $5.5 million. Recent developments include a $3.3 million July 2026 private placement and a cooperation agreement that reconstituted the board following shareholder activism.
Wearable Devices Ltd. (WLDS) reported first‑half 2026 results showing small but growing sales alongside significantly higher investment spending. Revenue for the six months ended June 30, 2026 rose to $350 thousand, up about 19% from $294 thousand a year earlier, mainly from B2C sales of the Mudra Band and Mudra Link.
The company’s operating loss widened to $5.9 million and net loss to $5.5 million, up 48.6% year over year, driven by higher research and development, sales and marketing, and general and administrative expenses, including increased headcount and share‑based compensation. Cash used in operating activities was $4.2 million in the half.
WLDS remains at an early revenue stage but is well capitalized, with $18.8 million in cash and short‑term deposits and $18.6 million of shareholders’ equity as of June 30, 2026, after a series of equity raises and warrant inducement transactions. Management states existing cash is expected to fund operations through mid‑2028, and the board and management believe cash is sufficient for at least one year from approval of the financial statements. A side letter with J.B.D Innovation Ltd. provides a contingent $12 million convertible debt financing commitment if future liquidity needs arise. The company also discloses recent activist‑driven board changes and notes that regional geopolitical tensions have, as of August 24, 2026, had no material impact on operations.
Wearable Devices Ltd. (WLDS) disclosed that Vardi Avichy Nisan, a director of the company, filed an initial statement of beneficial ownership on Form 3. The filing lists no reportable transactions or holdings in the non-derivative or derivative securities tables as of the reporting date.
Wearable Devices Ltd. (WLDS) reports that Adler Oz, a director of the company, has filed an initial statement of beneficial ownership on Form 3. The filing lists no equity transactions, derivative positions, or reportable holdings for Adler Oz at this time.
Wearable Devices Ltd. (WLDS) reported that Revach Hila Kiron is a director and filed an initial statement of beneficial ownership on Form 3. The filing lists no equity holdings and no reportable transactions or derivative positions for this reporting person as of the filing date.
Wearable Devices Ltd. (WLDS) reported that Kabazo Gabriel is a director of the company in an initial beneficial ownership statement. This Form 3 filing does not list any equity holdings or report any transactions or derivative positions for the reporting person.
Wearable Devices Ltd. (WLDS), an Israel-incorporated biotechnology/health care technology company, reported a completed exempt securities offering under Rule 506(b) of Regulation D. The company sold securities for aggregate gross proceeds of $3,284,924 USD, with no remaining amount to be sold. The offering involved equity, warrants or other rights to acquire securities, and the securities issuable upon exercise of those rights. The company notes that the total amount sold excludes any additional proceeds that may be received if the warrants are exercised in the future. A.G.P./Alliance Global Partners is identified in connection with a 7.0% cash fee and 1.0% management fee as placement agent compensation.
Armistice Capital, LLC and Steven Boyd report beneficial ownership of 167,513 Ordinary Shares of Wearable Devices Ltd., representing 4.99% of the class. These shares are held by Armistice Capital Master Fund Ltd., for which Armistice Capital is investment manager and exercises voting and investment power under an Investment Management Agreement.
Armistice Capital and Steven Boyd may be deemed to share voting and dispositive power over all 167,513 shares, while the Master Fund has the right to receive dividends and sale proceeds. The filing confirms ownership of 5 percent or less of the issuer’s outstanding Ordinary Shares.